Screening Proprietary Drug Names for Similarities: Research Design and Questionnaire Structure .
Challenges to Test Design
Expert Panels
But Limits on Ability of Experts to Predict Errors
Need to Test Expert Predictions
Assume We Want to Test the Name Taxol
Procedures for Testing
Instructions:
Questions Asked After Each Name Is Shown:
Other Cues
A Potential Approach When the Expert Panel Identifies A Particular Similarly Named Drug
“Line-up” Instructions
Caveats With The Line-up Approach
When Should the Questions Be Closed-Ended? IT DEPENDS
Focus Groups as a Substitute?
Problems in Validating
Future
Home Page: http://www.fda.gov/cder/meeting/drugNaming.htm
Download presentation source